S

SpringWorks Therapeutics
D

SWTX

58.240
USD
-1.66
(-2.77%)
مغلق
حجم التداول
145,563
الربح لكل سهم
-3
العائد الربحي
-
P/E
-17
حجم السوق
4,364,263,904
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
الأخبار
المقالات

العنوان: SpringWorks Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several otherprograms addressing highly prevalent, genetically defined cancers.